Bioduro

Bioduro company information, Employees & Contact Information

Explore related pages

Related company profiles:

BioDuro, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for 29 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ scientists and 7 global sites across 6 cities. Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline. For more information about BioDuro, please visit our website at www.bioduro.com

Company Details

Employees
486
Founded
-
Address
9601 Jeronimo Rd, Irvine,california 92618,united States
Phone
619-565-5679
Email
hr****@****uro.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Irvine, California
Looking for a particular Bioduro employee's phone or email?

Bioduro Questions

News

Silicogenix Partners with BioDuro to Accelerate Novel Drug Discovery for Complex Diseases - PR Newswire

Silicogenix Partners with BioDuro to Accelerate Novel Drug Discovery for Complex Diseases PR Newswire

BioDuro Expanding Drug-Substance Mfg, Peptide Scale-Up Capabilities - DCAT Value Chain Insights

BioDuro Expanding Drug-Substance Mfg, Peptide Scale-Up Capabilities DCAT Value Chain Insights

BioDuro opens high potency lab - Speciality Chemicals Magazine

BioDuro opens high potency lab Speciality Chemicals Magazine

BioDuro Opens New Lab in Shanghai - Contract Pharma

BioDuro Opens New Lab in Shanghai Contract Pharma

Christopher Conway joins BioDuro board to strengthen global leadership - Pharmafile

Christopher Conway joins BioDuro board to strengthen global leadership Pharmafile

BioDuro opens new R&D and manufacturing campus in China to support biopharma sector - BioSpectrum Asia

BioDuro opens new R&D and manufacturing campus in China to support biopharma sector BioSpectrum Asia

BioDuro boosts peptide production in China with new manufacturing plant - Fierce Pharma

BioDuro boosts peptide production in China with new manufacturing plant Fierce Pharma

Atombeat and BioDuro Announce Strategic Partnership to Launch an AI-Powered Platform for Accelerated Peptide Drug Discovery - PR Newswire

Atombeat and BioDuro Announce Strategic Partnership to Launch an AI-Powered Platform for Accelerated Peptide Drug Discovery PR Newswire

US’ BioDuro Expands Peptide Manufacturing with New Facility in China - ET Pharma

US’ BioDuro Expands Peptide Manufacturing with New Facility in China ET Pharma

Atombeat, BioDuro to launch peptide drug discovery platform - Pharmaceutical Technology

Atombeat, BioDuro to launch peptide drug discovery platform Pharmaceutical Technology

BioDuro Opens New Peptide Laboratory in Shanghai - Contract Pharma

BioDuro Opens New Peptide Laboratory in Shanghai Contract Pharma

BioDuro-Sundia Appoints Dr. Armin Spura as New Chief Executive Officer - Business Wire

BioDuro-Sundia Appoints Dr. Armin Spura as New Chief Executive Officer Business Wire

Solid-Phase Peptide Synthesis Scale-Up Facility Opened by BioDuro in Shanghai - BioPharm International

Solid-Phase Peptide Synthesis Scale-Up Facility Opened by BioDuro in Shanghai BioPharm International

From Hit to IND: Streamlining Drug Discovery Through Multidisciplinary Integration - Fierce Pharma

From Hit to IND: Streamlining Drug Discovery Through Multidisciplinary Integration Fierce Pharma

BioDuro-Sundia Expands Drug Discovery Capacity and Capability - Business Wire

BioDuro-Sundia Expands Drug Discovery Capacity and Capability Business Wire

BioDuro-Sundia Launches New Compound Management Center - Contract Pharma

BioDuro-Sundia Launches New Compound Management Center Contract Pharma

BioDuro announces cooperation agreement with Porton Pharma Solutions - PR Newswire

BioDuro announces cooperation agreement with Porton Pharma Solutions PR Newswire

BioDuro partners with Advent International - PR Newswire

BioDuro partners with Advent International PR Newswire

Advent to sell Bioduro stake, eyes valuation over $1bn - Private Equity Insights

Advent to sell Bioduro stake, eyes valuation over $1bn Private Equity Insights

BioDuro-Sundia Appoints Alan Findlater as CCO - Contract Pharma

BioDuro-Sundia Appoints Alan Findlater as CCO Contract Pharma

BioDuro-Sundia Expands Drug Discovery Capacity, Capability - Contract Pharma

BioDuro-Sundia Expands Drug Discovery Capacity, Capability Contract Pharma

BioDuro-Sundia opens new kilogram laboratory at Shanghai to speed development from discovery to preclincal and clinical phases - Pharmabiz.com

BioDuro-Sundia opens new kilogram laboratory at Shanghai to speed development from discovery to preclincal and clinical phases Pharmabiz.com

BioDuro-Sundia Appoints CEO - Contract Pharma

BioDuro-Sundia Appoints CEO Contract Pharma

Advent Said to Weigh Options Including $1.5 Billion BioDuro Sale - Bloomberg.com

Advent Said to Weigh Options Including $1.5 Billion BioDuro Sale Bloomberg.com

BioDuro-Sundia Brings Manufacturing to Irvine - Orange County Business Journal

BioDuro-Sundia Brings Manufacturing to Irvine Orange County Business Journal

Advent Makes Majority Investment in BioDuro - The Wall Street Journal

Advent Makes Majority Investment in BioDuro The Wall Street Journal

Why China’s contract research firms are doing more business at home - Chemical & Engineering News

Why China’s contract research firms are doing more business at home Chemical & Engineering News

Top Bioduro Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant